✦ LIBER ✦

The safety and 24-hour antihypertensive efficacy of the vasopeptidase inhibitor Omapatrilat: a pilot study

✍ Scribed by M. Ruddy; R. Guthrie; V. Papademetriou; K. Moulton; R. Saini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First dose response and 24-hour antihype

✍ Mary E. Heber; Geoffrey S. Brigden; Michael P. Caruana; Avijit Lahiri; Edward B. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 744 KB

A Pilot Study of the Safety Implications

✍ Dorrian, Jillian; Lamond, Nicole; van den Heuvel, Cameron; Pincombe, Jan; Rogers 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 280 KB

A pilot study of the clinical efficacy a

✍ William G. Ondo; Nicte I. Mejia; Christine B. Hunter 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Antihypertensive efficacy, safety, and t

✍ Matthew R. Weir; Christopher Bush; David R. Anderson; Jack Zhang; Deborah Keefe; 📂 Article 📅 2007 🏛 Elsevier 🌐 English ⚖ 1017 KB

Study of the safety and efficacy of ACE

✍ Jennifer Adgey; Malcolm Clarke; Ali Raza; David Meddis 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 314 KB

A pilot study of the safety and efficacy

✍ Joyce K Keithley; Barbara Swanson; Beverly E Sha; Janice M Zeller; Harold A Kess 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 44 KB